Rezolute advances therapies for hypoglycemia with RZ358 and RZ402, showing efficacy in trials. Read why RZLT stock is a compelling, albeit cautious, investment.

This leaflet answers some common questions about DBL™ Diazoxide Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.